Revolutionizing GERD diagnosis: how capsule sponge testing prioritizes high-risk patients while easing the strain on endoscopy services. Study: Clinical application of capsule sponge testing in ...
Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett's esophagus, a known precursor to esophageal cancer, according to a new study from ...
Please provide your email address to receive an email when new articles are posted on . A capsule-sponge test may help risk-stratify patients with Barrett’s esophagus. Patients classified as low risk ...
The researchers found that in the high-risk patient group, the positive predictive value for any dysplasia or worse was 37.7%. HealthDay News — In adult patients with nondysplastic Barrett esophagus ...
Hosted on MSN
'Pill-on-a-thread' could replace endoscopies for half of all patients being monitored for esophageal cancer risk
Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett's esophagus, a known precursor to esophageal cancer, according to a new study by ...
Cyted Ltd. received U.S. FDA 510(k) clearance for its Endosign capsule technology, a non-endoscopic capsule sponge device used to collect pan-esophageal samples to detect esophageal pre-cancer and ...
Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett’s oesophagus, a known precursor to oesophageal cancer, according to a new study from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results